Stage IB-IIB Cutaneous T-Cell Lymphoma research hub

Anti-CCR4 Monoclonal Antibody (Mogamulizumab) and Total Skin Electron Beam Therapy (TSEB) in Patients With Stage IB-IIB Cutaneous T-Cell Lymphoma

This study looks at a new way to treat specific stages of Cutaneous T-cell Lymphoma (CTCL) using a drug called mogamulizumab and a type of radiation therapy called Total Skin Electron Beam (TSEB). The aim is to find a treatment that works well with fewer side effects.